School of Pharmaceutical Sciences, Universiti Sains Malaysia

  • Qualification

    PhD (Groningen, NL), M. Pharm (Clin. Pharm) (USM), B.Pharm (Hon) (USM)

  • Senior Lecturer

    Discipline of Clinical Pharmacy

  • Academic Editor & Editorial Board Member

    PLOS One

  • Managing Editor

    Malaysian Journal of Human Genetics

  • Room

    J01 Room 130

  • Contact

    +604-6577888 Ext. 2412

  • Email

    aizati@usm.my

Author ID

Nur Aizati Athirah Binti Daud, Dr

I am a registered pharmacist, and obtained my BPharm (Hons) and MPharm(ClinPharm) degrees from School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM) Penang. I obtained my PhD in pharmacoepidemiology and pharmacogenomics from University of Groningen, the Netherlands. I am one of the selected participants of 68th Lindau Nobel Laureate Meeting in Germany in 2018, where I am inspired to contribute more to the scientific community.

Currently I am a senior lecturer in the Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, USM, a member of Malaysian Pharmacists Society (MPS) and Exco member of Islamic Medical Association Malaysia (IMAM). I am now active in teaching, research activities and postgraduate supervision in my areas of interest, which are pharmacogenomics and personalized medicine, women’s health, sexual and reproductive health, medication use during pregnancy, and drug abuse. I have published many research articles in national and international journals. I am also an Academic Editor and Editorial Board member of PLOS One journal and the managing editor of Malaysian Journal of Human Genetics. I have been invited as a speaker, moderator, or presenter for various international and national seminars, conferences, talks, online webinars, and events during my career life.

My current projects include genetic involvement in the risk of adverse reactions following the use of selected medications, the genotype-guided selection of medication for heart disease, belief about medication use during pregnancy and breastfeeding, vitamin D deficiency during pregnancy and its outcomes, and several others.

Starting 2019, I became an affiliate lecturer/researcher at Human Genome Center in Health Campus, Universiti Sains Malaysia. Here, my team is working on a setup for pharmacogenetic testing in the country, in line with the role of the pharmacogenomics field in preventive and precision medicine. As this field has been widely implemented in other countries, it is time for pharmacists to be actively involved in providing pharmaceutical care through the advancement of precision medicine in Malaysia.

  • Research Interest

    1. Pharmacogenomics and personalized medicine
    2. Pharmacoepidemiology
    3. Women health pharmacy
    4. Sexual/ Reproductive health pharmacy
    5. Drug use in pregnancy and lactation
    6. Drug abuse among female

    Ongoing Research

    1. HLA-genotypes and the risk of severe cutaneous adverse drug reaction associated with the use of antiepileptics. (Principal investigator, Short Term Grant, Oct 2019 - current)
    2. Belief about medicine use during pregnancy and breastfeeding (Prinicipal investigator, February 2020 - current)
    3. COVID-19 survey among pregnant and breastfeeding mothers (August 2021 - current)
    4. Menstrual health among Rohingya population in Malaysia (MESTRO): Investigating menstrual hygiene and practice needs among female Rohingya (August 2021 - current)
    5. Menstrual health hygiene and practice among female students in higher educational institutions in Malaysia (MAYA) (August 2021 - current)
    6. Studentsʼ learning experience, perception and satisfaction level on micro credential asynchronous online modules as part of pharmacy undergraduate program (April 2021 - current)
    1. Clinical pharmacy
    2. Pharmacogenomics
    3. Genetic association studies
    4. Pharmacoepidemiology
    5. Women Health Pharmacy
    1. 1. Awaludin, A.; Rahayu, C.; Daud, N.A.A.; Zakiyah, N. Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis. Healthcare 2022, 10, 325.
    2. Anandan A, Daud NAA, Kasinather VB, Narayanan S, Azman A, Singh DSM, Factors associated with drug use during pregnancy and breastfeeding among females who use drugs (FWUDs) in Malaysia, Journal of Ethnicity in Substance Abuse 2021, Dec 30;1-16.
    3. Ahmed AF, Sukasem C, Sabbah MA, Musa NF, Mohamed Noor DA, Daud NAA. Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions. Journal of Personalized Medicine. J. Pers. Med. 2021, 11, 383.
    4. Hoong CB, Govindasamy GS, Musa NF, Mohamed Noor DA, Daud NAA. Diagnostic Tests and Genetic Screening for Antiepileptic-Induced Severe Cutaneous Adverse Reactions (SCAR) in Resource Limited Setting. Malaysian Journal of Human Genetics (MJHG) | Vol. 2 (1) June 2021.
    5. Daud N.A.A, Mohiuddin, S.G., Ong Y.P., Yusof, F., Yusoff, F., Harun, S.N., Ghadzi S.M.S. (2021) Metformin Use in Gestational Diabetes: Awareness, Attitude and Practice Among Healthcare Professionals in Malaysia. Journal of Pharmacy and Bioallied Sciences, Pharm Bioall Sci 2021;13:230-7.
    6. Akkaif MA, Ng ML, Abdul Kader MASK, Daud NAA, Shaʼaban A, Ibrahim B. A review of the effects of ticagrelor on adenosine concentration and its clinical significance. Pharmacological Reports, 20 July 2021, https://doi.org/10.1007/s43440-021-00309-0.
    7. The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD). Molecules 2021, 26, 1987.
    8. Ong SC, Chhabra IK, Ooi GS, Daud NAA, Shafie AA, Ahmad Hassali. Reliability and Validity of the Malay Version of the Return and Disposal of Unused Medications (Redium) Questionnaire in Malaysia and the General Publicʼs Knowledge, Attitude and Practice on Unused Medications. Malaysian Journal of Medicine and Health Sciences, Mal J Med Health Sci 17(3): 22-30, July 2021.
    9. Singh D, Anandan A, Narayanan S, Daud NAA, Azman A, Vicknasingam B (2021). Factors associated with intimate partner violence and barriers to reporting it, among female who use drugs in Malaysia. Drugs: Education, Prevention and Policy, https://doi.org/10.1080/09687637.2021.1941777
    10. Hanapi, NNM, SC Ong, GS Ooi, Daud NAA. Sleep quality and quality of life among Malaysian pharmacy undergraduate students. Malaysian Journal of Pharmaceutical Sciences Vol. 19, No. 1, 65–75 (2021).
    11. Daud, NAA. Mukhlef, SA, Abdul Aziz, F. Awareness, Attitude and Behaviour on the Intake of Maternal Dietary Supplements among Malaysian Pregnant Women. Malaysian Journal of Medicine and Health Sciences (2020); 16(4): 51-55.
    12. Daud, A. N. A., et al. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research. BMC Pregnancy and Childbirth (2017); 17(1), 120.
    13. Daud, A. N. A. et al. Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies. PLoS ONE (2017); 12(3), 1–14.
    14. Daud, A. N. et al. Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study. Pharmacogenomics (2017), 18(10):987-1001.
    15. Daud, A. N. A. et al. The risk of congenital heart anomalies following prenatal exposure to serotonin reuptake inhibitors—Is pharmacogenetics the key? International Journal of Molecular Sciences (2016), 17(8), 1333.
    16. Daud, ANA, et al. Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins. Pharmacogenomics (2014); 15(7):1029–1041.
    17. Daud, ANA et al. P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study. Drug Safety (2015); 38(7):651–659.
    1. Member, Malaysian Pharmacists Society (MPS)
    2. EXCO member, Islamic Medical Association Malaysia (IMAM)
    3. Academic Editor & Editorial Board Member, PLOS One Journal
    4. Managing Editor, Malaysian Journal of Human Genetics
    5. Affiliate Lecturer/Researcher, Human Genome Center, Universiti Sains Malaysia Health Campus
    1. FAR153 Communication Skills in Pharmacy Practice
    2. FAR352 Clinical Pharmacy Practice
    3. FEL374 Drug and Society
    4. FAR454 Applied Therapeutics II
    5. FAR459 Pharmacogenomics
    6. FCP558 Clinical Pharmacy Practice
    7. FCP559 Biostatistics and Research Methodology
    8. FCP561 Medicine Clerkship
    9. HFE 224 Penghayatan Etika dan Peradaban
    1. Best Oral Presenter (IMAM Annual Scientific Conference 2022): 'The Effectiveness of Menstrual EducationModule for Children and Adolescent Refugees: A Pilot Study'
    2. Hadiah Sanjungan (Penerbitan Jurnal) 2021: 'Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions, JOURNAL OF PERSONALIZED MEDICINE'
    3. Hadiah Sanjungan (Penerbitan Jurnal) 2021: 'The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD), MOLECULES'
    4. Hadiah Sanjungan (Penerbitan Jurnal) 2021: 'A review of the effects of ticagrelor on adenosine concentration and its clinical significance, PHARMACOLOGICAL REPORTS'
    5. Hadiah Sanjungan (Penerbitan Jurnal) 2021: 'Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials, JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE'

School of Pharmaceutical Sciences
11800 Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Tel : +604-653 2211  |  Fax: +604-657 0017